A thyroid tumor about 4 cm in diameter was removed from a 53-year-old female.
Medullary carcinoma of the thyroid (MCT) was first regarded as a clinical entity by Hazard et al. (1959) , recognizing a group of solid non-follicular tumors with comparatively good prognosis among apparently undifferentiated carcinomas. The C-cell or parafollicular cell of the thyroid was suggested as the origin of MCT by Williams (1966a) . The C-cell belongs to the category of so-called APUD (amine precursor uptake and decarboxylation) cell series. MCT and the C-cell were found to share common unique biological characteristics, such as the production of various kinds of polypeptide hormones, confirming the C-cell as the origin of MCT.
A wide variation of morphological futures and prognosis of MCT had already been pointed out by Williams et al. (1966b) , and even some anaplastic carcinomas were found to be of a C-cell nature (Kruseman et al., 1982) . However, recent reports disclosed new aspects of MCT, which lie beyond the scope of mere variation. Firstly, some MCT are thyroid hormone-dependent (Wahner et al., 1968 ; Didolkar and Moore, 1974 ; Hales et al., 1982) . Secondly, some possible MCT not only have a follicular pattern but also produce thyroglobulin (Valenta et al., 1977 ; Hales et al., 1982 ; Pfaltz et al., 1983 ; Endocrinol. Japon. February 1984 Ljungberg et al., 1983) . Furthermore, MCT with mucus production is reported (Fernandes et al., 1982) . Thirdly, Kameda et al. (1978 Kameda et al. ( , 1979 found a thyroglobulin-like substance (C-Thyroglobulin) in the C-cells and also in MCT. Calmettes et al. (1982) reported thyroid carcinomas with a poorly differentiated follicular pattern, which produced calcitonin (CT) and carcinoembryonic antigen (CEA), proposing these carcinomas as a new clinical entity. Consequently, the concept that the C-cell and MCT are derived from the neural crest and quite different from the follicular epithelial cells seems to be not so valid.
Another enigma of MCT is the rarity of its benign counterpart, i.e., C-cell adenoma. In rats, C-cell hyperplasia, C-cell adenoma (or focal C-cell hyperplasia), and C-cell carcinomas are not infrequently observed, and their serial progression is estimated (Boorman and DeLellis, 1983) . In humans, nodule formation of C-cells is occasionally found in the normal thyroid (Gibson etal., 1981) , and even C-cell hyperplasia has been observed in the thyroid tissue of familial MCT cases (Wolfe et al., 1973) . But to the best of our knowledge, no C-cell adenoma, certainly not a large one, has ever been reported.
The tumors reported as C-cell adenomas by Beskid etal. (1971) seem to be hardly acceptable as genuine ones, becase of the lack of any substantial proof.
Elevation of not only serum CT but also CEA levels in MCT was first reported by Ishikawa and Hamada (1976) and Hamada et al. (1976) , and well confirmed by others (Calmettes et al., 1978 ; Kodama et al., 1979) . CEA was also identified in the C-cell of the normal thyroid (Kodama et al., 1980) and proved to be a useful marker of nontumorous and tumorous C-cells. Of interest is the report of Rougier et al. (1983) that CEA is a more meaningful tumor marker capable of defining a high-risk subgroup than CT, although the latter seems to be more sensitive than the former in detecting A 53-year-old female patient visited our clinic on March 22, 1983, complaining of a tumor of five months' duration in the left thyroid region.
The tumor was soft, round, smooth-surfaced, well movable and about 4 cm in diameter.
Concomitantly, another tumor, measuring 1.5 x 1.2 cm, was found in the right parotid region.
It proved to be an adenolymphoma after operation, but this was not a matter of concern in the study.
There was no personal or family history of any other endocrine disorders. Thyroid function tests were within normal limits.
The tumor exhibited no calcification on the soft X-ray film of the neck. By ultrasound sonography, it was found to be homogeneously solid and well demarcated from the surrounding thyroid tissues. She was admitted to our hospital on April 26 for surgical excision of the thyroid and parotid tumors. Routine laboratory studies revealed no abnormalities. Left lobectomy of the thyroid (and resection of the superficial lobe of the right parotid gland) was performed on May 2, under the diagnosis of a follicular adenoma without any complications. After the thyroid tumor was proved to be of C-cell nature, urinary catecholamines and their metabolites were assayed, considering the possibility of Sipple's syndrome,i.e., association of pheochromocytomas, but they were normal and computed tomography revealed no adrenal mass lesions. The post-operative course was uneventful, and the patient was discharged from the hospital on May 16. radioimmunoassay was performed in the Mitsubishiyuka Laboratory of Medical Science Co., Tokyo, the normal range being less than 200 pg/ml and 2.5 ng/ml, respectively.
Results

Gross findings
The tumor situated at the upper portion of the left thyroid lobe, being apparently encapsulated and measuring 4 cm in diameter.
On the cut surface, brown to gray tumor tissue stood up above the rim with a very thin capsule (Fig. 1) .
It was indistinguishable from a common microfollicular adenoma.
Microscopical findings
The tumor was composed of compact cell nests with no follicle formation. The cells were uniform and medium-sized, having fusiform or cuboidal acidphilic cytoplasm and comparatively small elliptical nucleus. Mitotic figures were scarcely observed. It was enormously rich in the small vessels and the capillaries, around which fusiform cells were arrayed in radial fashion (Fig. 2) . No abnormalities were found in the neighboring thyroid tissues. Encapsulation of the tumor was incomplete, without even thin fibrous capsule depending on the location , but neither infiltrative growth nor vascular invasion was observed.
Radioimmunoassay of serum CT and CEA The exact nature of the tumor was not clear only from the microscopical findings, but extremely high levels of CT, i.e., 2065 and 1420 pg/ml, were found in the stored serum taken pre-operatively.
The serum level of CT decreased down to the normal range soon after the operation. Serum CEA levels were less than 2.5 ng/ml, pre-and post-operatively (Fig. 3) . Serum CT and CEA remained low, being 19 pg/ml and 2.1 ng/ml respectively, at the last visit to the out-patient clinic, about five months after the operation.
Histochemical and immunohistochemical studies
Amyloid deposition was not demonstrated in the tumor tissue, but the tumor cells proved to be argyrophil (Fig. 4) . The tumor cells were found to contain CT (Fig. 5) , but no other polypeptide hormones, such as glucagon, somatostatin and ACTH. Contrary to expectation, CEA was also positive (Fig.   6 ). Thyroglobulin was negative, and its presence was demonstrated only in the nontumorous follicles left around the periphery of the tumor and small cell clusters in the vicinity of these follicles (Fig. 7) . Serum CEA is known to be sensitive enough to diagnose MCT, though the sensitivity may be somewhat less than that of CT. Accordingly, the normal serum CEA value of this patient with a tumor as large as 4 cm in diameter denotes, most logically, the possibility that this tumor produces CEA but dose not secrete it, at least in large amounts.
MCT patients with high CEA values are reported to have a poorer prognosis than those with low CEA values (Rougier et al., 1981) . The reverse may also be true, and the normal CEA value of this case is able to be interpreted as suggesting its benign nature.
Several kinds of polypeptide hormones other than CT were identified in MCT (Iwanaga et al., 1978 Kameya et al., 1983 . Generally speaking, the multi-hormonal activities of endocrine tumors tend to suggest their malignant behavior.
In this case, only CT activity was demonstrated, and this observation is also in favor of its benign nature.
From this study, no direct proof was obtained for or against the concept of the C-cell as the exclusive origin of MCT. But, from many aspects already mentioned, this tumor may be interpreted as an C-cell adenoma, or to say the least, to represent most differentiated types of MCT, though differentiation between these is difficult at present.
To the best of our knowledge, this type of tumor has not yet been reported, but it seems conceivable that these tumors have not been closely studied and are regarded only as eccentric adenomas.
